A longitudinal analysis of maternal serum insulin-like growth factor I (IGF-I) and total and nonphosphorylated IGF-binding protein-1 in human pregnancies complicated by intrauterine growth restriction

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 4, 2002, Pages 1864-1870

  Bhatia, S ^a,b   Faessen, G H ^a,c,d   Carland, G ^a,c,d   Balise, R L ^a,c,d   Gargosky, S E ^a,c,d   Druzin, M ^a,c,d   El Sayed, Y ^a,c,d   Wilson, D M ^a,c,d   Giudice, L C ^a,c,d  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Diagostics Systems Laboratories Inc   (United States)

^c CHILDREN S HOSPITAL OAKLAND   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; AMNIOCENTESIS; AMNION FLUID; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREGNANCY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0036277967     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.4.8418     Document Type: Article

References (31)

1. Relationship between birthweight and blood pressure in childhood
2. Fetal nutrition and cardiovascular disease in adult life
3. Recognition of a new association: Reduced fetal growth, precocious pubarche, hyperinsulinism and ovarian dysfunction
4. Glucose but not a mixed amino acid infusion regulates plasma insulin-like growth factor-I concentrations in fetal sheep
5. Effect of a high maternal dietary intake during mid-gestation on components of the utero-placental insulin-like growth factor (IGF) system in adolescent sheep with retarded placental development
6. Maternal insulin-like growth factor-I infusion alters feto-placental carbohydrate and protein metabolism in pregnant sheep
7. Insulin-like growth factor 1 alters feto-placental protein and carbohydrate metabolism in fetal sheep
8. Current concepts of fetal growth restriction. II. Diagnosis and management
9. The insulin-like growth factor-I/binding protein axis: Physiology, pathophysiology and therapeutic manipulation
10. Insulin-like growth factor binding protein-1: Recent findings and new directions
11. Regulation of IGF bioavailability in pregnancy
12. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth
13. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: Relation to fetal weight
14. Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy
15. Insulin-like growth factor I in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation
16. Maternal hypoxia as a model for intrauterine growth retardation: Effects on insulin-like growth factors and their binding proteins
17. Effects of acute hypoxemia on insulin-like growth factors and their binding proteins in fetal sheep
18. Prolonged hypoxia induced by the reduction of maternal uterine blood flow alters insulin-like growth factor-binding protein-1 (IGFBP-1) and IGFBP-2 gene expression in the ovine fetus
19. Hypoxia stimulates insulin-like growth factor binding protein 1 (IGFBP-1) gene expression in HepG2 cells: A possible model for IGFBP-1 expression in fetal hypoxia
20. Insulin-like growth factor-binding protein-1 in umbilical artery and vein of term fetuses with signs suggestive of distress during labor
21. Gestational age-dependent expression of insulin-like growth factor- binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy
22. Insulin-like growth factor-binding protein-1, glucose tolerance and fetal growth in human pregnancy
23. Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy
24. 1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures
25. 1 integrin via mitogen-activated protein kinase pathway
26. A United States national reference for fetal growth
27. Somatomedins in pregnancy: A cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies
28. Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth
29. Insulin-like growth factor binding protein 1 level in amniotic fluid: Correlation with birth weight
30. Elevated second-trimester amniotic fluid concentration of insulin-like growth factor binding protein-1 in fetal growth retardation
31. IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth